WCN26-3667 PATIENT EXPERIENCES WITH CANNABIDIOL FOR SYMPTOM MANAGEMENT IN KIDNEY FAILURE: QUALITATIVE INSIGHTS FROM THE SEISMIC-CBD TRIAL

Read full text Summarise with VIRAT
Authors: Tae Won Yi, Brendan J Smyth, Kristy P. Robledo, Iain S. McGregor, Andrew J. McLachlan, Rachael Lisa Morton, Meg Jardine
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Results: The cohort (N=150) had a mean age of 52.5 +/-12.8years, with 65.3% male and a high median dialysis vintage of 32 months (IQR: 18-60 months).We observed a marked disparity between physical and mental well-being: the mean PCS score (40.1 +/-11.5)was profoundly diminished compared to established general population norms, while the MCS score (51.2 +/-10.4) was relatively preserved, suggesting significant mental resilience in the face of physical decline.The most debilitating disease-specific domain scores were the Symptom/Problem List (45.2 +/-15.1)and the Burden of Kidney Disease (49.8 +/-14.5).Crucially, correlational analysis revealed a strong and statistically significant negative association between long-term dialysis vintage (>5 years) and PCS scores (r = -0.38,p

Fields of Study & Subjects

Cannabis and Cannabinoid Research Dialysis and Renal Disease Management Cancer survivorship and care

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104111–104111
Publication date
25 March 2026
Language
EN